🩸 THE FRAUD THEY PUBLISHED — WHO SOLD THE WORLD A SCIENTIFIC PROMISE?
From Fabricated COVID-19 Vaccine Research to the Global Media Amplification Machine — Who Verifies the Evidence Before the Headlines Reach Millions?
Red Blood Journal | Investigative Report | November 6, 2026
I. THE DISCOVERY THAT BECAME A HEADLINE
On July 27, 2022, while the world was still struggling with the consequences of the COVID-19 pandemic, an apparently promising scientific discovery entered the international news cycle. Researchers in London were reported to have identified a possible path toward a vaccine capable of protecting against multiple coronaviruses, including future variants and viruses associated with the common cold.
The research appeared in Science Translational Medicine, a prestigious peer-reviewed journal published by the American Association for the Advancement of Science (AAAS). Within the same news cycle, media organizations began reporting its promise. The Guardian, The National, specialized biotechnology publications, and science-communication organizations helped bring the findings to audiences far beyond the scientific community.
The proposition sounded encouraging. Instead of developing vaccines that repeatedly needed updating as viruses changed, scientists might eventually target a more stable portion of the coronavirus spike protein and produce broader immune protection.
But four years later, on October 14, 2026, the journal formally retracted the study after an institutional investigation established that it contained fabricated experimental data and falsified images.
The scientist identified as responsible, Kevin W. Ng, had admitted responsibility, according to the journal’s retraction notice. Some additional experimental findings could no longer be independently verified because original data and samples were unavailable.
The discovery that had traveled through the scientific publication system and into international headlines was now officially discredited.
The question confronting the public is no longer simply why one scientist fabricated evidence. It is how so many institutions helped transform unverified research into widely distributed scientific news—and what responsibility those institutions have when the evidence collapses.
This investigation examines the documented chain of publication and publicity, the difference between scientific fraud and media responsibility, and the possibility that institutional incentives create a system in which favorable scientific promises travel faster than their eventual corrections.
II. WHAT THE SCIENTISTS CLAIMED — AND WHAT THEY FABRICATED
The original research was titled SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies. It investigated whether an experimental vaccination strategy targeting the S2 portion of the coronavirus spike protein could produce antibodies capable of recognizing multiple coronaviruses.
The spike protein contains different regions. The S1 region includes areas that change substantially as variants evolve, while S2 contains portions that are more conserved across related viruses. Researchers hoped that targeting S2 might help generate broader immunity, potentially improving protection against variants or even other coronaviruses.
The experiments were principally conducted in mice. They explored how previous exposure to a common-cold coronavirus could influence immune responses and whether an S2-targeting experimental vaccine could generate broadly neutralizing antibodies.
This was not a clinical trial demonstrating that a universal coronavirus vaccine worked in humans. Nor was it the original evidence used to authorize the COVID-19 vaccines already administered to the public.
Nevertheless, the paper presented findings suggesting a promising direction for future vaccine development.
The Francis Crick Institute’s subsequent investigation determined that data in Figure 2B and Figure 2C had been fabricated and that images in supplementary Figure S6 had been falsified. The journal further acknowledged that the documented fabrication undermined confidence in other experiments whose original data or samples were unavailable for independent verification.
This is not a dispute over how to interpret ambiguous results. The retraction documents the fabrication and falsification of research evidence.
The distinction matters. Scientific disagreement is a normal and necessary part of research. Deliberately manufacturing experimental evidence is an attack on the reliability of the scientific record itself.
The finding does not prove that every theory concerning S2 vaccination is wrong. It establishes that this particular publication cannot be relied upon as legitimate evidence for its conclusions.
III. THE FIRST GATEKEEPER — THE SCIENTIFIC PUBLISHER
Before a medical discovery becomes a newspaper headline, it often receives credibility from the journal that accepts and publishes it.
In this case, that journal was Science Translational Medicine, operated by AAAS, the scientific association associated with the journal Science.
The journal’s publication of the study provided a powerful signal of credibility. Researchers, journalists, institutional press offices, and readers could see that the findings had entered the peer-reviewed scientific literature.
But what exactly does peer review guarantee?
Peer review generally asks qualified researchers to examine a manuscript’s methods, reasoning, presentation, and conclusions. Reviewers may question experiments, request additional analysis, or recommend rejection. Yet they do not necessarily possess the original laboratory materials, independently recreate every experiment, or authenticate every numerical value supplied by an author.
In other words, an article can survive peer review even when some underlying evidence has been manipulated or invented.
That limitation does not establish that the journal knowingly published fraudulent material. It does, however, raise a legitimate question about the standards governing research that may influence public understanding, future medical development, and potentially enormous financial investments.
When a prestigious publisher gives credibility to a discovery, how much responsibility does it retain for checking the evidence behind that discovery?
And when the journal eventually withdraws the research, should issuing a retraction be considered the completion of its responsibility, or the beginning of a broader accountability process?
IV. THE SECOND GATEKEEPER — THE INSTITUTION BEHIND THE RESEARCH
The research involved scientists affiliated with the Francis Crick Institute in London, a major biomedical research organization.
The institute’s reputation contributed institutional credibility to the publication. Its scientists were identified in news reports, and their interpretations helped journalists explain the proposed discovery to the public.
The institute later investigated concerns involving Ng’s research and identified the misconduct that contributed to the withdrawal of the coronavirus study.
This investigation was not an isolated development. On January 14, 2026, Nature retracted another publication involving Ng, concerning antibodies against endogenous retroviruses and lung cancer immunotherapy. Investigators had identified manipulated or unverifiable research data associated with his analyses.
The earlier findings prompted an examination of additional work involving the researcher, eventually uncovering the problems in the 2022 coronavirus paper.
According to statements from the institute reported by Retraction Watch, investigators found no evidence of malpractice by the other authors of the coronavirus study.
That finding must be respected. Responsibility for one researcher’s misconduct should not automatically be assigned to colleagues without supporting evidence.
Nevertheless, institutional accountability extends beyond identifying who fabricated a result. Universities and research institutes also have responsibilities involving supervision, data retention, research integrity, and systems intended to detect misconduct.
The questions remain: Were the original measurements independently examined before publication? What records should have been preserved? What verification processes existed, and why did they not identify the fabricated material before it entered the scientific literature?
The answers are important not because every institution should be presumed guilty, but because institutional reputation alone cannot substitute for verifiable evidence.
V. THE THIRD GATEKEEPER — THE MEDIA AMPLIFICATION NETWORK
The most revealing part of this story may be what happened after the scientific paper was published.
On July 27, 2022, The Guardian reported the research as a promising step toward developing a vaccine that could address COVID-19 and common-cold coronaviruses. The article identified the Francis Crick Institute and included comments from researchers explaining why targeting the S2 region might be useful.
The National published its own account describing hopes for a broad coronavirus vaccine. Specialized science and biotechnology coverage also helped spread awareness of the findings.
Meanwhile, the UK Science Media Centre published expert reactions to the study, presenting commentary from scientists and medical specialists intended to help journalists understand the research.
These organizations performed different functions. The scientific journal published the original evidence. The research institute supplied scientific authority and researcher commentary. Science-communication intermediaries helped journalists interpret the findings, while news organizations presented the discovery to general audiences.
Together, they formed an identifiable chain through which research moved from specialized laboratories into public consciousness.
OrganizationDocumented role in the information chainAAAS / Science Translational MedicinePublished the original scientific article and later its retractionFrancis Crick InstituteResearch institution associated with the study; subsequently investigated the misconductScience Media CentrePublished expert reactions concerning the study on July 27, 2022The GuardianReported the proposed vaccine discovery to mainstream readersThe NationalPublished international coverage of the experimental findingsGenetic Engineering & Biotechnology NewsProvided specialist biotechnology coverage of the proposed S2 strategyPA Media and other news distributorsPart of the broader news-distribution trail identified in contemporary coverage, requiring further tracing for this specific story
The documented publication and coverage do not establish that these organizations coordinated to deceive the public. It would be incorrect to treat every scientific news report as evidence of knowing participation in fraud.
But the sequence reveals something worth investigating: a claim can move rapidly through a network of institutions while each participant depends, at least partly, on the credibility granted by an earlier participant.
A journalist trusts a peer-reviewed paper. An editor trusts a journalist’s reporting. A reader trusts the newspaper. Another publication may then summarize the coverage, and social media can extend its reach further.
At no point does every participant necessarily inspect the original laboratory evidence.
The result is a system capable of distributing scientific credibility at enormous speed, even when the evidence generating that credibility is fundamentally defective.
VI. THE SCIENCE MEDIA CENTRE — WHO SHAPES THE SCIENTIFIC MESSAGE?
The Science Media Centre deserves particular examination because its institutional purpose involves connecting scientific expertise with news reporting.
Unlike a conventional newspaper, it functions as an intermediary between researchers and journalists. Its published expert reactions can help shape which scientific interpretations reporters encounter when preparing their stories.
On the day the S2 paper appeared in 2022, the Science Media Centre published commentary discussing the experimental findings and the possibility of developing a broader coronavirus vaccine.
There is nothing inherently improper about helping journalists obtain expert opinions. Accurate science communication is valuable, especially when complicated scientific concepts are being reported under deadline pressure.
The accountability question concerns how such commentary is selected, funded, framed, and corrected.
Who chooses the experts? How are financial and institutional conflicts of interest addressed? Are dissenting interpretations included when scientifically justified? Does the organization follow up when a study receiving its attention is subsequently discredited?
These are questions about transparency and institutional process, not accusations of proven misconduct.
However, intermediary organizations occupy a position of influence that deserves public scrutiny. They can help determine which research becomes visible, which expert voices receive attention, and how scientific uncertainty is communicated to millions of readers.
The issue is not whether scientific experts should speak to journalists. It is whether the public can adequately examine the systems that select and amplify those expert voices.
VII. THE GLOBALIST AGENDA QUESTION — COORDINATION OR STRUCTURAL ALIGNMENT?
Whenever multiple influential institutions distribute similar messages, some observers interpret the pattern as evidence of a coordinated global agenda.
But before applying that description to these publishers, a distinction must be made between three possibilities.
The first is ordinary news convergence. Multiple outlets may report the same discovery because it appeared in a respected journal, offered apparent scientific significance, and was accompanied by accessible researcher commentary.
The second is structural alignment. Research institutions, scientific publishers, media organizations, public-health agencies, and commercial interests can operate within overlapping professional networks, financial relationships, and institutional incentives. Those connections may influence which subjects receive attention and how they are framed without requiring explicit coordination to mislead.
The third possibility is intentional manipulation. This would involve evidence that identifiable parties knowingly promoted false information or coordinated misleading messaging to advance specific interests.
The currently verified evidence supports the existence of scientific fraud and a documented publicity chain. It does not establish that the named news organizations knowingly participated in the fraud or operated under a unified global political agenda.
Nevertheless, structural alignment is a legitimate investigative subject.
If researchers benefit from publication prestige, institutions benefit from visibility, journals benefit from influential discoveries, and news organizations benefit from compelling scientific headlines, those incentives can reinforce one another.
Such a system does not have to be controlled by a single hidden authority to develop predictable patterns of behavior.
The central question becomes whether existing incentives reward the promotion of promising findings more strongly than their rigorous verification and subsequent correction.
That possibility can be tested through financial disclosures, institutional relationships, editorial practices, publicity records, and comparisons of coverage over time.
An investigation that follows those records is far more powerful than attaching a political label to every organization participating in the information chain.
VIII. FOUR YEARS LATER — WHO INFORMED THE PUBLIC THAT THE STUDY WAS FALSE?
On October 14, 2026, Science Translational Medicine formally retracted the coronavirus vaccine paper.
By that point, the publication had accumulated 83 citations in Clarivate’s Web of Science, according to Retraction Watch.
That figure does not mean that 83 other studies became fraudulent or invalid. A citation can refer to background material, methodological comparisons, or disputed findings. Nevertheless, it shows that the paper had entered the wider research record.
Retraction Watch reported the misconduct and the circumstances surrounding the journal’s decision. The journal published its official withdrawal, and the scientific record was updated.
But another investigation remains necessary.
How many of the media outlets that reported the original discovery also reported its retraction? Did they update their original articles? Did they attach visible warnings to earlier coverage? Did their readers receive a correction with prominence comparable to the original announcement?
The articles reviewed for this report establish that the research was publicized in July 2022. They do not establish a complete accounting of every subsequent correction or follow-up story by those publishers.
Therefore, it would be premature to accuse every outlet of deliberately suppressing the retraction.
But the comparison is both possible and necessary.
A news organization that celebrates a discovery has an opportunity to revisit that reporting when the discovery’s supporting paper is formally withdrawn.
And readers should not be expected to monitor scientific retraction databases years after encountering a promising medical headline.
The problem is one of proportional responsibility. Scientific promises can shape public expectations, future research interests, and perceptions of medical progress. Corrections should be sufficiently visible to reach the audiences originally exposed to claims that no longer have reliable support.
IX. FOLLOW THE MONEY — WHO BENEFITED?
The original paper’s indexed record identifies research support associated with organizations including the UK’s Medical Research Council, the Wellcome Trust, and Cancer Research UK.
These funding acknowledgments establish associations with research support. They do not prove that those organizations financed fabricated experiments knowingly, directed misconduct, or benefited from deception.
Nor does the existence of a funding relationship prove that a pharmaceutical company controlled the study or that the findings were developed to promote an already marketed vaccine.
Those are separate claims requiring separate evidence.
Nevertheless, the financial relationships deserve careful examination because scientific research operates within a larger system of grant awards, institutional budgets, publication incentives, intellectual-property opportunities, and professional advancement.
A positive research result may improve the perceived significance of a project. Publication in a major journal may increase institutional visibility and strengthen future funding applications. Media attention may extend the commercial or academic interest surrounding an experimental technology.
Such benefits are possible even if no participant intended to deceive the public.
The investigative task is to establish what actually happened in this case. Which grants supported the relevant experiments? Were those experiments used in progress reports or subsequent funding applications? Were funds recovered or disciplinary actions imposed? Did anyone pursue commercial development based materially on the withdrawn findings?
Without the underlying records, the answers remain unproven.
Following the money is meaningful only when the investigation follows identifiable transactions, decisions, and beneficiaries—not merely the existence of wealthy institutions.
X. WHAT THIS CASE DOES NOT PROVE
Because this investigation concerns COVID-19 vaccine research, it is essential not to confuse a fabricated experimental paper with the entire body of vaccine science.
The retracted publication investigated a proposed S2-targeting vaccination strategy, primarily through mouse experiments. It was not the central evidence establishing the efficacy of the COVID-19 vaccines already authorized and distributed internationally.
The fraud therefore does not demonstrate that every COVID-19 vaccine was ineffective, unsafe, or approved through fabricated evidence.
Nor does the retraction establish that every scientist, journalist, medical institution, or public-health organization involved in coronavirus research was dishonest.
These distinctions do not weaken the investigation. They preserve its credibility.
The confirmed misconduct is serious enough without adding claims unsupported by the evidence.
The strongest criticism is not that all science is fraudulent. It is that respected scientific institutions can publish fraudulent results and that surrounding information systems may amplify those results before anyone detects the underlying deception.
That is an accountability failure worthy of examination in its own right.
XI. THE SYSTEM THAT DOES NOT NEED A CONSPIRACY
Imagine a scientific ecosystem in which researchers compete for recognition, institutions compete for funding, journals compete for influential publications, and news organizations compete for attention.
Each participant may believe it is performing a legitimate professional function. A researcher seeks a discovery, a journal seeks important science, an institution seeks recognition, and a newspaper seeks an informative headline.
Yet the combined system may create pressure to emphasize significant findings while making verification expensive, slow, or professionally unrewarding.
A fabricated discovery can exploit those conditions without requiring a centralized conspiracy.
That possibility is arguably more troubling than the existence of a single dishonest researcher, because replacing that researcher does not automatically correct the incentives surrounding the publication process.
The same system may continue rewarding exciting conclusions more readily than careful replication, rewarding publicity more readily than correction, and rewarding institutional prestige more readily than transparent acknowledgment of failure.
The solution cannot simply be to abandon confidence in science. It must be to identify the conditions under which scientific credibility can be earned, independently tested, and withdrawn when justified.
Trust should follow verification, not precede it unconditionally.
XII. THE QUESTIONS THE PUBLISHERS SHOULD ANSWER
Four years after the original publication, the most productive public response is to ask the institutions involved to explain their procedures and make their records available wherever appropriate.
AAAS and Science Translational Medicine should be asked what authentication procedures were applied before the original study was published, whether changes have followed the retraction, and how the journal is notifying researchers who may have relied on the withdrawn findings.
The Francis Crick Institute should be asked how original experimental data were preserved, what supervisory safeguards were in place, and what institutional lessons emerged from the investigations involving Ng’s publications.
Science Media Centre should be asked whether its original 2022 commentary has been updated to identify the subsequent retraction, and how it determines whether earlier science-publicity materials require visible corrections.
The Guardian, The National, specialist biotechnology outlets, and relevant news distributors should be asked how they handle research stories when the underlying publication is later withdrawn for confirmed fabrication.
Finally, research funders should be asked whether the misconduct triggered reviews of grant reporting, funding compliance, or subsequent applications that may have relied on the disputed findings.
The objective should be measurable transparency, not guilt by association.
If the system is functioning properly, it should be able to demonstrate how fabricated evidence was identified, corrected, and prevented from continuing to influence research and public understanding.
XIII. HOW READERS CAN FIGHT BACK
The public should not have to become a collection of professional laboratory auditors to evaluate every medical news report. Nevertheless, several practical habits can reduce dependence on institutional authority alone.
When encountering a scientific headline, readers can examine whether the research involved humans, animals, or laboratory cells; whether the findings were preliminary or independently replicated; and whether the article accurately distinguishes experimental possibilities from established medical benefits.
Readers can also examine the original publication, search for subsequent corrections or retractions, and compare several independent sources rather than treating repeated coverage as independent confirmation.
Most importantly, audiences can demand that media organizations visibly update stories when the underlying evidence changes. A correction should be readily discoverable by someone encountering the original article years later.
There is also a responsibility to resist selective skepticism. Evidence should be subjected to scrutiny whether it supports or challenges one’s preferred beliefs.
Replacing unquestioning trust in official institutions with unquestioning trust in alternative commentators would simply transfer the same problem to another source of authority.
Independent thinking requires consistent standards.
🩸 THE RED BLOOD PERSPECTIVE — THE POWER TO PUBLISH IS NOT THE POWER TO PROVE
A researcher fabricated data. A respected scientific journal published a paper containing that fabricated data. Major news organizations reported its promise. Four years later, the paper was formally withdrawn, and the scientific record was corrected.
Those are the documented events.
The remaining questions concern the institutions whose authority and distribution systems helped the original claims travel around the world.
The public should not confuse the absence of proof of a coordinated agenda with proof that institutional incentives are harmless. Financial interests, reputational rewards, professional relationships, and editorial choices can shape the information environment even without explicit instructions from a central authority.
But suspicion is not a substitute for evidence either. Before calling organizations participants in a deliberate global deception, investigators must establish the relevant communications, financial relationships, decisions, and knowledge.
The distinction between documented conduct and inferred motive is the foundation of a defensible investigation.
Red Blood Journal’s position is that no institution should enjoy immunity from scrutiny because of its prestige, and no institution should be declared guilty merely because it operates within an influential network.
The question is not whether people should trust science or reject it. The question is whether they are given sufficient evidence to evaluate the claims made in science’s name.
When institutions ask the public to trust their authority, the public has every right to demand that those institutions demonstrate their accountability.
🌊❤️✨ THE OCEAN OF LOVE AND POSITIVITY PERSPECTIVE — TRUTH WITHOUT HATRED
The discovery of scientific misconduct can generate anger, especially when the subject involves a pandemic that affected millions of families. That anger can be understandable, but it does not have to become hostility toward every scientist, journalist, physician, or individual who accepted the research in good faith.
One dishonest action can expose weaknesses in a larger system without establishing that every person within that system is dishonest.
The task of a thoughtful society is to encourage people to question authority while remaining open to genuine evidence, to demand accountability without abandoning fairness, and to support the researchers who pursue truth even when their discoveries contradict institutional expectations.
Love and positivity do not require overlooking deception. They require refusing to let deception transform our desire for truth into indiscriminate hatred.
The deepest form of independence is not merely the ability to reject what someone else tells us. It is the ability to recognize when our own assumptions also require examination.
A healthy world needs honest researchers, responsible publishers, courageous journalists, and citizens willing to ask difficult questions without surrendering compassion.
Science becomes stronger when mistakes are exposed, records are preserved, whistleblowers are protected, and correction is valued over reputation.
The goal is not to destroy public trust. It is to build a world in which trust can be deserved.
SOURCES AND RESEARCH DOCUMENTATION
Primary scientific record
Ng, K. W., et al. (2022). SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies. Science Translational Medicine, 14(655). Original article, now retracted.
https://pubmed.ncbi.nlm.nih.gov/35895836/Vinson, V., and Smith, O. (2026). Retraction of the Research Article “SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies”. Science Translational Medicine, October 14, 2026.
https://pubmed.ncbi.nlm.nih.gov/42873900/Nature. (2026). Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy. January 14, 2026.
https://www.nature.com/articles/s41586-026-10104-7
Contemporary media coverage
The Guardian. (2022). UK scientists take ‘promising’ step towards single Covid and cold vaccine. July 27, 2022.
https://www.theguardian.com/world/2022/jul/27/uk-scientists-take-promising-step-towards-single-covid-and-cold-vaccineScience Media Centre. (2022). Expert reaction to a mouse study of a pan-coronavirus vaccine. July 27, 2022.
https://www.sciencemediacentre.org/expert-reaction-to-a-mouse-study-of-a-pan-coronavirus-vaccine/The National. (2022). Scientists raise hope for ‘pan-coronavirus’ vaccine that protects against common cold. July 27, 2022.
https://www.thenationalnews.com/health/2022/07/27/scientists-raise-hope-for-pan-coronavirus-vaccine-that-protects-against-common-cold/
Independent research-integrity reporting
Retraction Watch. (2026). Former Crick Ph.D. student loses COVID vaccine paper for fabrication. October 14, 2026.
https://retractionwatch.com/2026/10/14/former-crick-ph-d-student-loses-covid-vaccine-paper-for-fabrication/Francis Crick Institute. Research integrity news and investigation statements.
https://www.crick.ac.uk/about-us/our-approach-to-science/research-integrity/2025-research-integrity-news
Editorial note: This report distinguishes documented research misconduct, verified publication activity, institutional incentives, and hypotheses regarding broader coordination. Its discussion of institutional alignment is investigative analysis, not a finding that the named publishers knowingly participated in fraud. A comprehensive audit of each publisher’s post-retraction coverage and funding relationships remains an open research task.
🩸🌊❤️✨ — Ocean of Love and Positivity
Blood connects us. The ocean unites us. Love guides us. Positivity illuminates our path.
📄
The Anatomy of Scientific Fraud and Media Amplification
Nov 6, 2026
An investigative report from the Red Blood Journal examines how a fabricated COVID-19 vaccine study regarding a universal coronavirus vaccine bypassed peer review and spread globally through mainstream media. The Science Translational Medicine paper, authored by researchers at the Francis Crick Institute, was formally retracted four years later after investigators confirmed data fabrication and falsified images. Although the text highlights systemic failures in institutional oversight and rapid media amplification, it stresses that the misconduct does not invalidate the broader body of vaccine science. Ultimately, the sources call for rigorous accountability and transparent corrections rather than unquestioning trust in institutional authority or unsubstantiated conspiracy theories.